CME/CE: Anticoagulant Use Among Afib Patients Wanes Over Time

Publication Date:
Tue, 12/01/2015
By: Alere Staff

SPONSORED BY

MedPage Today

American Heart Association

ACTIVE DATE

November 11, 2015 – November 11, 2017

CREDIT

Physicians: 0.25 AMA PRA Category 1 Credit(s) ™

DESCRIPTION

Barely half of patients with atrial fibrillation who were prescribed rivaroxaban to prevent stroke remained on the treatment after two years, but their adherence was still better than Afib patients on warfarin or dabigatran. The study suggests that physicians have to address the common attitudes of patients who are taking drugs for chronic, asymptomatic diseases to help improve adherence.

LINK

http://www.medpagetoday.com/clinical-context/Strokes/54645